New fibromyalgia drug shows promise in Long-Term safety trial
NCT ID NCT07637162
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the long-term safety and effectiveness of an experimental drug called AXS-14 for people with fibromyalgia, a condition causing widespread pain and fatigue. About 300 adults who previously took part in a related study will receive AXS-14 for 52 weeks. Researchers will monitor side effects to see if the drug is safe for extended use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Santa Ana, California, 92705, United States
-
Clinical Research Site
Jacksonville, Florida, 32256, United States
-
Clinical Research Site
Orlando, Florida, 32801, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Atlanta, Georgia, 30329, United States
-
Clinical Research Site
Louisville, Kentucky, 40205, United States
-
Clinical Research Site
Tulsa, Oklahoma, 74133, United States
-
Clinical Research Site
Charleston, South Carolina, 29407, United States